Clinical Trial

Curative Chemoradiation of Low Rectal Cancer

Study acronym: WW2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the present study is to investigate whether curative chemoradiation of low rectal cancer is feasible, safe and effective in a multicenter study with results comparable to those of single center studies. Results from previous studies indicate that a considerable fraction of patients with low rectal cancer can be cured by a combination of radiation and chemotherapy alone and thus be spared from operation.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2015-05-05; most recent amendment 2026-01-06.
Status change: Recruiting → Active, Not Recruiting 2020-01-09
Trial Details
NCT Number NCT02438839
Lead Sponsor Vejle Hospital
Conditions Rectal Cancer
Enrollment 108 participants
Start Date 2015-09
Primary Completion 2022-03-17 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-08